N4-Benzoyl-2'-O-propargyladenosine manufacturers
|
| | N4-Benzoyl-2'-O-propargyladenosine Basic information |
| Product Name: | N4-Benzoyl-2'-O-propargyladenosine | | Synonyms: | N4-Benzoyl-2'-O-propargyladenosine;2'-O-(1-propyn-3-yl)-6-N-benzoyladenosine;N6-Benzoyl-2’-O-(2-propyn-1-yl)adenosine;Adenosine, N-benzoyl-2'-O-2-propyn-1-yl-;2'-O-propargyl-rA(Bz);N6-Benzoyl-2’-O-propargyl adenosine | | CAS: | 210096-44-9 | | MF: | C20H19N5O5 | | MW: | 409.4 | | EINECS: | | | Product Categories: | | | Mol File: | 210096-44-9.mol |  |
| | N4-Benzoyl-2'-O-propargyladenosine Chemical Properties |
| | N4-Benzoyl-2'-O-propargyladenosine Usage And Synthesis |
| Uses | N-Benzoyl-2′-O-2-propyn-1-yladenosine is an adenosine analog. Adenosine analogs mostly act as smooth muscle vasodilators and have also been shown to inhibit cancer progression. Its popular products are adenosine phosphate, Acadesine (HY-13417), Clofarabine (HY-A0005), Fludarabine phosphate (HY-B0028) and Vidarabine (HY-B0277)[1]. N-Benzoyl-2′-O-2-propyn-1-yladenosine is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups. | | References | [1] Man S, et al. Potential and promising anticancer drugs from adenosine and its analogs. Drug Discov Today. 2021 Jun;26(6):1490-1500. DOI:10.1016/j.drudis.2021.02.020 |
| | N4-Benzoyl-2'-O-propargyladenosine Preparation Products And Raw materials |
|